Evidence map›Paper›PMID 28877877›Full record

ArticleAmerican journal of physiology. Renal physiology2018

Acute blood loss stimulates fibroblast growth factor 23 production.

Seham Rabadi, Ikemesit Udo, David E Leaf, Sushrut S Waikar, Marta Christov

Open access · bronzeAbstract read
In one paragraph

Article in American journal of physiology. Renal physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men.Pflugers Archiv : European journal of physiology · 2018
    Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Non-Classical Effects of FGF23: Molecular and Clinical Features.International journal of molecular sciences · 2024
    Review
  9. Associations between anemia and FGF23 in the CKiD study.Pediatric nephrology (Berlin, Germany) · 2024
    Article
  10. Exploring endocrine FGFs - structures, functions and biomedical applications.International journal of biochemistry and molecular biology · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. C-Terminal, but Not Intact, FGF23 and EPO Are Strongly Correlatively Elevated in Patients With Gain-of-Function Mutations in HIF2A: Clinical Evidence for EPO Regulating FGF23.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021
    Article
  20. Upstream Regulators of Fibroblast Growth Factor 23.Frontiers in endocrinology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Seham RabadiDepartment of Medicine, New York Medical College, Valhalla, New York.
Ikemesit UdoDepartment of Medicine, New York Medical College, Valhalla, New York.
David E LeafDivision of Renal Medicine, Brigham and Women's Hospital , Boston, Massachusetts.
Sushrut S WaikarDivision of Renal Medicine, Brigham and Women's Hospital , Boston, Massachusetts.
Marta ChristovDepartment of Medicine, New York Medical College, Valhalla, New York.
New York Medical College · USBrigham and Women's Hospital · US

Funding

Dysregulated Mineral Metabolism and Acute Kidney InjuryK23DK106448 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI LEAF, DAVID EVAN · 2015 to 2019
$964k
Dissecting the Mechanisms that control FGF23K08DK093608 · NIDDK · NEW YORK MEDICAL COLLEGE · PI CHRISTOV, MARTA · 2012 to 2016
$752k
NIDDK NIH HHS K08 DK093608NIDDK NIH HHS K23 DK106448
6 · The paper itself

Abstract

Fibroblast growth factor 23 (FGF23) production is upregulated by iron deficiency and hypoxia. However, the influence of acute blood loss, and the resulting increases in circulating erythropoietin, on FGF23 production is unknown. Using wild-type C57BL/6 mice, we show that acute loss of 10% total blood volume leads to an increase in plasma C-terminal FGF23 (cFGF23) levels within 6 h, while plasma levels of intact FGF23, phosphate, calcium, parathyroid hormone, iron, and ferritin remain similar to control mice without acute blood loss. Volume resuscitation with PBS did not significantly alter these findings. The increase in plasma cFGF23 levels in bled animals was accompanied by increased plasma erythropoietin levels at 6 h. Administration of erythropoietin led to an acute increase in plasma cFGF23 levels similar to that observed in acute blood loss. Fgf23 mRNA expression was increased 20-fold in bone marrow, but not in bone, of bled vs. control mice, suggesting bone marrow as a key source of elevated plasma FGF23 levels following acute blood loss. To extend these findings to humans, we measured plasma cFGF23 levels in 131 critically ill patients admitted to the intensive care unit. In univariate and multivariate models, we found a positive association between number of red blood cell transfusions, an indirect indicator of acute blood loss, and plasma cFGF23 levels. We conclude that FGF23 production is rapidly increased after acute blood loss and that erythropoietin may be the mediator of this increase. Thus erythropoietin may represent a novel physiological regulator of FGF23 production.

Indexed as

AnimalsBlood Loss, SurgicalCalciumErythropoiesisFibroblast Growth Factor-23Fibroblast Growth FactorsHomeostasisIronMice, Inbred C57BLModels, BiologicalCalciumFGF23 protein, humanFgf23 protein, mouseFibroblast Growth Factor-23Fibroblast Growth FactorsIronanemiableedingerythropoietinFGF23iron

Identifiers

PMID28877877
PMCPMC5866351
OpenAlexW2753738233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.